EnGagE : Enhancing Psychiatric Genetic Counselling, Testing, and Training in Europe
Date and time
Location
Institute of Psychiatry and Neuroscience of Paris - "Amphithéâtre Blanc"
102 Rue de la Santé 75013 Paris FranceRefund Policy
Description
The COST Action EnGagE organizes a workshop in Paris entitled « the Principles of Psychiatric Genetic Testing & Counselling » on April 11-12th.
The last decade has witnessed major advances in psychiatric genetics. Research have received wide media coverage and awareness among patients and their family members leading to an increased demand for high-quality information on psychiatric genetics. However, development of the psychiatric testing and counseling in Europe is heterogeneous and a framework to facilitate the implementation of both disciplines into routine clinical care is lacking. The COST Action EnGagE aimed to strengthen pan-European research into the newly emerging disciplines of Psychiatric Genetic Counselling and Psychiatric Genetic Testing.
This first workshop of the Action aims to bring together child and adult psychiatrists, psychologists, clinical geneticists, genetic counselors, and students from all over Europe to develop a shared culture. The two days will be split in four sections :
- Thursday morning: “Presentation of the French initiatives in psychiatric genetics and introduction to psychiatric disorders”
- Thursday afternoon: “Introduction to genetic counseling”
- Friday morning: “Introduction to genetic testing”
- Friday afternoon: “Patient perspectives”
Lunch and coffee breaks will be offered.
A call for poster presentation is opened. If interested, please send an email to boris.chaumette@inserm.fr
Organisation committee: Dr. Boris Chaumette, Pr. David Cohen, Dr. Franziska Degenhardt, Pr. Marie-Odile Krebs, Dr. Claudine Laurent-Levinson
Program
Thursday, April 11th
9.00-9.30 : Welcome introduction (T. Galli, MO. Krebs, F. Degenhardt)
9.30-10.00 : Presentation of the French initiatives: Reference Center for Rare Psychiatric Diseases, DefiScience network and France Genomic 2025 Initiative (D. Cohen)
10.00-10.30 : The genetic architecture of autism from risk to resilience (T. Bourgeron)
Coffee Break and Networking
Session Psychiatric Disorders
11.00-11.30 : Introduction to Psychiatric disorders (B. Chaumette)
11.30-12.00 : Clinical neurogenetics of psychiatric disorders (A. Poisson)
12.00-12.30 : Clinical red flags for organicity in schizophrenia (O. Bonnot)
12.30-13.00 : Medical and genetic risk factors in early-onset psychosis (C. Laurent-Levinson)
Lunch, Poster session and Networking
Session Genetic Counselling
14.00-14.30 : Psychiatric information and genetic counselling - How are we doing? (A. Cuthbert)
14.30-15.30 : Clinical and personal utility of genetic diagnoses in individuals with neuropsychiatric disorders (B. Finucane)
15.30-16.00 : Discussion and questions
Coffee break and Networking
16.30-17.30 : Artificial intelligence for facial images: is there a characteristic gestalt in schizophrenia? (P. Krawitz)
17.30-18.30 : Recent and future developments in medical genetics (S. Lyonnet
19.00-22.00 : Dinner (by invitation only)
Friday, April 12th
Session Genetic Testing
9.00-9.45 : Short introduction to genetic testing with focus on chromosomal microarray (K. Tammimies)
9.45-10.15 : Medical consequences of pathogenic CNVs among carriers in the UK biobank (G. Kirov)
10.15-10.30 : Round table discussion
Coffee break and Networking
11.00-12.00 : 22q11.2 deletion syndrome and the clinical application of genetic testing and genetic counselling for major psychiatric illness (A. Bassett)
12.00-13.00 : Modelling the effect-size of rare variants, genome-wide, on cognitive and behavioural traits (S. Jacquemont)
Lunch, Poster session and Networking
Session Patient perspectives
14.00-14.30 : New therapeutic advances in Prader-Willi syndrome (M. Tauber)
14.30-15.15 : Unique: Supporting & informing families and professionals challenged by rare chromosome & genome disorders (B. Searle)
15.15-15.30 : Discussion and closing remarks
After 15.30 : Tour of the Institute of Psychiatry and Neuroscience of Paris and the Sainte-Anne hospital
L'Action COST EnGagE organise à Paris un atelier intitulé «Les principes du dépistage génétique et du conseil psychiatriques» les 11 et 12 avril.
La dernière décennie a été témoin d'avancées majeures en génétique psychiatrique. Les recherches ont bénéficié d'une large couverture médiatique et d'une prise de conscience parmi les patients et les membres de leur famille, ce qui a entraîné une demande accrue d'informations de qualité sur la génétique psychiatrique. Cependant, le développement du conseil et des tests psychiatriques en Europe est hétérogène et un cadre facilitant la mise en œuvre des deux disciplines dans les soins cliniques de routine fait défaut. L'action EnGagE vise à renforcer la recherche paneuropéenne sur les disciplines émergentes du conseil génétique en psychiatrie et des tests génétiques psychiatriques. Ce premier atelier de l'action vise à réunir des psychiatres pour enfants et adultes, des psychologues, des généticiens cliniques, des conseillers en génétique et des étudiants de toute l'Europe pour développer une culture commune.
Les deux jours seront divisés en quatre sections:
- Jeudi matin: «Présentation des initiatives françaises en génétique psychiatrique et introduction aux troubles psychiatriques»
- Jeudi après-midi: "Introduction au conseil génétique"
- Vendredi matin: "Introduction aux tests génétiques"
- Vendredi après-midi: “Perspectives du patient”
Le déjeuner et les pauses café seront offerts.
Un appel à la présentation par affiches est ouvert. Si vous êtes intéressé, veuillez envoyer un email à boris.chaumette@inserm.fr
Comité d'organisation: Dr. Boris Chaumette, Pr. David Cohen, Dr Franziska Degenhardt, Pr. Marie-Odile Krebs, Dre Claudine Laurent-Levinson
Organised by
The Institute of Psychiatry brings together 33 research teams from the Psychiatric Research Group (GDR 3557), associated clinical, academic and sector teams, as well as biotechnology companies. We have created a transdisciplinary research collaborative space by decompartmentalizing disciplines to accelerate progress and foster therapeutic innovation. Promoting the prevention of disorders, preventing chronicization and psychic disability, and improving care for the most resistant illnesses are at the heart of our concerns.
L’institut de Psychiatrie rassemble 33 équipes de recherche du Groupe de Recherche en Psychiatrie(GDR 3557), des équipes cliniques associées, universitaires ou de secteur, ainsi que des entreprises de biotechnologie.
Nous avons créé un espace collaboratif de recherche transdisciplinaires en décloisonnant les disciplines afin d’accélérer le progrès et de favoriser l’innovation thérapeutique. Favoriser la prévention des troubles, empêcher la chronicisation et le handicap psychique, améliorer les soins pour les formes les plus résistantes sont au coeur de nos préoccupations.